Categories Earnings, LATEST, Technology

Earnings Preview: Cognizant’s revenue to grow 8% in Q3

Cognizant Technology Solutions Corporation (CTSH) is set to report third-quarter 2018 earnings results on Tuesday, October 30, before market opens. Wall Street expects the company to report EPS of $1.13, reflecting a year-over-year growth of 12.9%. Revenue is anticipated to grow 8.3% to $4 billion.

Looking at the past four quarters, Cognizant has consistently surpassed estimates on earnings but on revenue, the company has come shy twice. The firm is seeing good demand for its various solutions such as cloud and analytics.

Cognizant’s strategy of acquiring different companies has proved fruitful as these acquisitions have helped the firm boost its cloud portfolio and digital capabilities as well as acquire a large customer base. The technology giant is also focusing its efforts on increasing its strategic client base. However, Cognizant continues to face numerous headwinds such as competitive pressures in the information technology sector.

In the second quarter, Cognizant surpassed earnings estimates but missed on revenues. Revenues grew 9% to $4 billion while earnings grew 28% to $1.19 per share. The company also saw revenue growth across all segments and regions.

For the third quarter, Cognizant provided an outlook for revenues in the range of $4.06 billion to $4.10 billion and EPS of $1.13. For full-year 2018, the company expects revenues of $16.05 billion to $16.30 billion and earnings of at least $4.50 per share.

Looking at the past three months, Cognizant’s shares are down 13% while over the past one month, the stock is down 6%. The stock was down 1.3% as of 2:50 pm ET on Friday.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top